HEADER TRANSFERASE 22-DEC-20 7BE4 TITLE CRYSTAL STRUCTURE OF MAP KINASE P38 ALPHA IN COMPLEX WITH INHIBITOR TITLE 2 SR159 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CRK1,MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA,MAP COMPND 5 KINASE P38 ALPHA; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAPK14, CRK1, CSBP1, CSBP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MAPK14, KINASE INHIBITOR, STRUCTURE-GUIDED DESIGN, STRUCTURAL KEYWDS 2 GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.JOERGER,M.SCHROEDER,S.ROEHM,S.KNAPP,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 31-JAN-24 7BE4 1 REMARK REVDAT 2 14-SEP-22 7BE4 1 JRNL REVDAT 1 03-MAR-21 7BE4 0 JRNL AUTH S.ROHM,B.T.BERGER,M.SCHRODER,D.CHATTERJEE,S.MATHEA, JRNL AUTH 2 A.C.JOERGER,D.M.PINKAS,J.C.BUFTON,A.TJADEN,L.KOVOORU, JRNL AUTH 3 M.KUDOLO,C.POHL,A.N.BULLOCK,S.MULLER,S.LAUFER,S.KNAPP JRNL TITL DEVELOPMENT OF A SELECTIVE DUAL DISCOIDIN DOMAIN RECEPTOR JRNL TITL 2 (DDR)/P38 KINASE CHEMICAL PROBE. JRNL REF J.MED.CHEM. V. 64 13451 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34506142 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00868 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.334 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 22769 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.994 REMARK 3 FREE R VALUE TEST SET COUNT : 1137 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.6000 - 4.1994 0.97 2854 143 0.1823 0.2155 REMARK 3 2 4.1994 - 3.3333 0.97 2742 137 0.1804 0.2364 REMARK 3 3 3.3333 - 2.9120 0.98 2727 158 0.2267 0.2728 REMARK 3 4 2.9120 - 2.6458 0.97 2676 151 0.2290 0.2784 REMARK 3 5 2.6458 - 2.4562 0.99 2738 127 0.2535 0.3108 REMARK 3 6 2.4562 - 2.3114 0.99 2742 151 0.2442 0.2922 REMARK 3 7 2.3114 - 2.1956 0.89 2440 130 0.4034 0.5595 REMARK 3 8 2.1956 - 2.1000 0.99 2713 140 0.2761 0.3535 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.294 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.576 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.33 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2690 REMARK 3 ANGLE : 1.006 3663 REMARK 3 CHIRALITY : 0.061 418 REMARK 3 PLANARITY : 0.006 485 REMARK 3 DIHEDRAL : 16.938 1626 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 4 THROUGH 123 ) REMARK 3 ORIGIN FOR THE GROUP (A): -9.6331 -2.1543 -16.9883 REMARK 3 T TENSOR REMARK 3 T11: 0.3560 T22: 0.3985 REMARK 3 T33: 0.4525 T12: 0.0185 REMARK 3 T13: -0.0947 T23: 0.0439 REMARK 3 L TENSOR REMARK 3 L11: 3.5015 L22: 3.0229 REMARK 3 L33: 3.3153 L12: 0.4772 REMARK 3 L13: -0.1381 L23: -0.3770 REMARK 3 S TENSOR REMARK 3 S11: 0.0314 S12: 0.5320 S13: 0.3433 REMARK 3 S21: -0.4689 S22: 0.1166 S23: 0.8810 REMARK 3 S31: 0.0085 S32: -0.7068 S33: -0.1212 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 124 THROUGH 218 ) REMARK 3 ORIGIN FOR THE GROUP (A): 12.6249 -1.4718 -18.2436 REMARK 3 T TENSOR REMARK 3 T11: 0.2123 T22: 0.2085 REMARK 3 T33: 0.1965 T12: 0.0124 REMARK 3 T13: -0.0063 T23: 0.0392 REMARK 3 L TENSOR REMARK 3 L11: 6.3551 L22: 3.1083 REMARK 3 L33: 4.9903 L12: 0.2749 REMARK 3 L13: -1.2919 L23: 1.7044 REMARK 3 S TENSOR REMARK 3 S11: 0.0195 S12: 0.2768 S13: 0.0470 REMARK 3 S21: -0.1871 S22: -0.1441 S23: -0.0113 REMARK 3 S31: -0.0160 S32: -0.0141 S33: 0.1496 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 219 THROUGH 352 ) REMARK 3 ORIGIN FOR THE GROUP (A): 17.0206 -6.1647 -13.7639 REMARK 3 T TENSOR REMARK 3 T11: 0.2975 T22: 0.2523 REMARK 3 T33: 0.1544 T12: -0.0159 REMARK 3 T13: -0.0437 T23: 0.0531 REMARK 3 L TENSOR REMARK 3 L11: 3.9299 L22: 1.8636 REMARK 3 L33: 1.6622 L12: 0.5151 REMARK 3 L13: -0.6691 L23: -0.2028 REMARK 3 S TENSOR REMARK 3 S11: 0.0963 S12: -0.1601 S13: -0.0166 REMARK 3 S21: -0.0720 S22: -0.1596 S23: -0.2362 REMARK 3 S31: -0.0445 S32: 0.3204 S33: 0.0774 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7BE4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292113143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23058 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 78.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LAR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% MMW PEG SMEAR, 0.1M MES PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.23000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.09500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.62000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.09500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.23000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.62000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 VAL A 117 REMARK 465 LYS A 118 REMARK 465 CYS A 119 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 MET A 198 REMARK 465 HIS A 199 REMARK 465 TYR A 200 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 ARG A 5 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 10 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 LEU A 13 CG CD1 CD2 REMARK 470 ASN A 14 CG OD1 ND2 REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 GLU A 22 CG CD OE1 OE2 REMARK 470 GLN A 25 CG CD OE1 NE2 REMARK 470 LYS A 45 CG CD CE NZ REMARK 470 LYS A 79 CD CE NZ REMARK 470 ARG A 94 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 GLN A 120 CG CD OE1 NE2 REMARK 470 LEU A 195 CG CD1 CD2 REMARK 470 ASN A 196 CG OD1 ND2 REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 ASN A 257 CG OD1 ND2 REMARK 470 TYR A 258 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 259 CG1 CG2 CD1 REMARK 470 GLN A 264 CG CD OE1 NE2 REMARK 470 LYS A 267 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 352 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 11 146.03 -170.25 REMARK 500 PRO A 21 135.21 -37.67 REMARK 500 SER A 32 51.65 -110.35 REMARK 500 ASN A 100 -14.98 -149.99 REMARK 500 ARG A 149 -16.09 78.08 REMARK 500 ILE A 193 52.68 -92.51 REMARK 500 MET A 194 24.41 -147.79 REMARK 500 LEU A 195 -11.15 -169.86 REMARK 500 SER A 252 109.01 -54.37 REMARK 500 GLN A 264 108.73 -58.92 REMARK 500 PHE A 274 53.22 -98.72 REMARK 500 LEU A 289 51.21 -99.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TK5 A 401 DBREF 7BE4 A 1 360 UNP P47811 MK14_MOUSE 1 360 SEQADV 7BE4 GLY A 0 UNP P47811 EXPRESSION TAG SEQRES 1 A 361 GLY MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU SEQRES 2 A 361 LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN SEQRES 3 A 361 ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL SEQRES 4 A 361 CYS ALA ALA PHE ASP THR LYS THR GLY HIS ARG VAL ALA SEQRES 5 A 361 VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS SEQRES 6 A 361 ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS SEQRES 7 A 361 MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE SEQRES 8 A 361 THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR SEQRES 9 A 361 LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE SEQRES 10 A 361 VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE SEQRES 11 A 361 LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SEQRES 12 A 361 SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 361 LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP SEQRES 14 A 361 PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY SEQRES 15 A 361 TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET SEQRES 16 A 361 LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SEQRES 17 A 361 SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG SEQRES 18 A 361 THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS SEQRES 19 A 361 LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU SEQRES 20 A 361 LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE SEQRES 21 A 361 GLN SER LEU ALA GLN MET PRO LYS MET ASN PHE ALA ASN SEQRES 22 A 361 VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU SEQRES 23 A 361 GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR SEQRES 24 A 361 ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR SEQRES 25 A 361 HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP SEQRES 26 A 361 GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP SEQRES 27 A 361 LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO SEQRES 28 A 361 PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET TK5 A 401 47 HETNAM TK5 5-AZANYL-~{N}-[[4-[[(2~{S})-4-CYCLOHEXYL-1-[[(3~{R})-1- HETNAM 2 TK5 METHYLSULFONYLPIPERIDIN-3-YL]AMINO]-1-OXIDANYLIDENE- HETNAM 3 TK5 BUTAN-2-YL]CARBAMOYL]PHENYL]METHYL]-1-PHENYL-PYRAZOLE- HETNAM 4 TK5 4-CARBOXAMIDE FORMUL 2 TK5 C34 H45 N7 O5 S FORMUL 3 HOH *64(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 SER A 95 PHE A 99 5 5 HELIX 3 AA3 ASN A 114 ILE A 116 5 3 HELIX 4 AA4 THR A 123 ALA A 144 1 22 HELIX 5 AA5 LYS A 152 SER A 154 5 3 HELIX 6 AA6 ALA A 184 ARG A 189 5 6 HELIX 7 AA7 PRO A 191 LEU A 195 5 5 HELIX 8 AA8 THR A 203 GLY A 219 1 17 HELIX 9 AA9 ASP A 227 GLY A 240 1 14 HELIX 10 AB1 GLY A 243 LYS A 248 1 6 HELIX 11 AB2 SER A 252 LEU A 262 1 11 HELIX 12 AB3 ASN A 269 VAL A 273 5 5 HELIX 13 AB4 ASN A 278 LEU A 289 1 12 HELIX 14 AB5 THR A 298 ALA A 304 1 7 HELIX 15 AB6 HIS A 305 ALA A 309 5 5 HELIX 16 AB7 ASP A 313 GLU A 317 5 5 HELIX 17 AB8 GLN A 325 ARG A 330 5 6 HELIX 18 AB9 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 GLU A 12 0 SHEET 2 AA1 2 ILE A 17 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 5 TYR A 24 PRO A 29 0 SHEET 2 AA2 5 VAL A 38 ASP A 43 -1 O ALA A 40 N SER A 28 SHEET 3 AA2 5 ARG A 49 LYS A 54 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 3 ALA A 111 ASP A 112 0 SHEET 2 AA3 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA3 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 13 TYR A 35 VAL A 38 ALA A 51 ARG A 70 SITE 2 AC1 13 GLU A 71 ILE A 84 THR A 106 HIS A 107 SITE 3 AC1 13 MET A 109 LEU A 167 ASP A 168 GLY A 170 SITE 4 AC1 13 HOH A 536 CRYST1 66.460 75.240 78.190 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015047 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013291 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012789 0.00000